PTU - Polskie Towarzystwo Urologiczne
home page
current numbers
archival numbers
list of articles:
list przewodni/covering letter
editor
Scientific Committee
publisher
subscription
advertising
important links

Photoselective vaporization of the prostate (PVP) in the treatment of benign prostatic hyperplasia
Article published in Urologia Polska 2007/60/2.

authors

Henryk Zieliński, Grzegorz Piotrowicz, Leszek Bortnowski
Klinika Urologii Centralnego Szpitala Klinicznego Ministerstwa Obrony Narodowej, Wojskowy Instytut Medyczny w Warszawie

keywords

prostate, benign prostatic hyperplasia (BPH), surgical treatment, laser

summary

Current gold standard of treatment of benign prostatic hyperplasia (BPH) is transurethral electroresection of the prostate (TURP), but new methods, more comfortable and safer for the patients, are still developed. One of the most promising techniques is photoselective vaporization of the prostate (PVP) with potassium-titanyl-phosphate (KTP) laser.
The authors present indications and contraindications for PVP, operative technique, perioperative management and the results of treatment. Little invasiveness and morbidity as well as relatively easy technique with good objective and subjective outcome make PVP an optimal modern method of surgical treatment of BPH, possibly new gold standard.

references

  1. Costello AJ, Bowsher WG, Bolton DM et al: Laser ablation of the prostate in patients with benign prostate hypertrophy. Br J Urol 1992, 69, 603-608.
  2. Cowles RS 3rd, Kabalin JN, Childs S et al: A prospective randomized comparison of transurethral resection to visual ablation of the prostate for the treatment of benign prostatic hyperplasia. Urology 1995, 46, 155-160.
  3. Pypno W, Husiatyński W: Przezcewkowa laserowa ablacja stercza. Urol Pol 1996, 49, 48-52.
  4. Sengor F, Gurdal M, Tekin A et al: Neodymium: YAG visual laser ablation of the prostate: 7 years experience with 230 patients. J Urol 2002, 167, 184-187.
  5. McAllister WJ, Absalom MJ, Mir K I et al: Does endoscopic laser ablation of the prostate stand the test of time? Five-years results from a multicentre randomized controlled trial of endoscopic laser ablation against transurethral resection of the prostate. BJU Int 2000, 85, 437-439.
  6. Pypno W, Husiatyński W: Przezcewkowa laserowa ablacja stercza - cztery lata doświadczeń. Urol Pol 1998, 51, 236-243.
  7. Hofstetter A: Interstitielle thermokoagulation (ITK) von prostatentumoren. Lasermedizin 1991, 7, 179.
  8. Liedberg F, Adell L, Hagberg G, Palmqvist IB: Interstitial laser coagulation versus transurethral resection of the prostate for benign prostatic enlargement - a prospective randomized study. Scand J Urol Nephrol 2003, 37, 494-497.
  9. Gilling PJ, Cass CB, Malcolm AR, Fraundorfer MR: Combination holmium and Nd: YAG laser ablation of the prostate: initial clinical experience. J Endourol 1995, 9, 151-153.
  10. Kuntz RM, Lehrich K: Transurethral holmium laser enucleation versus transvesical open enucleation for prostate adenoma greater than 100 gm.: a randomized prospective trial of 120 patients. J Urol 2002, 168, 1465-1469.
  11. Kuntz RM, Ahyai S, Lehrich K, Fayad A: Transurethral holmium laser enucleation of the prostate versus transurethral electrocautery resection of the prostate: a randomized prospective trial in 200 patients. J Urol 2004, 172, 1012-1016.
  12. Seki N, Mochida O, Kinukawa N et al: Holmium laser enucleation for prostatic adenoma: analysis of learning curve over the course of 70 consecutive cases. J Urol 2003, 170, 1847-1850.
  13. Stępień S: Warsztaty laseroterapii gruczolaka stercza. Pierwsza w Polsce enukleacja laserem tulowym o fali ciągłej. Przeg Urol 2005, 1 (29), 33-35.
  14. Lipiński M, Peszyński-Drews C, Jeromin M, Jeromin L: Własne doświadczenia w leczeniu łagodnego rozrostu stercza wysokoenergetycznym laserem potasowo-tytanowo-fosforowym. Wiad Lek 2006, 59,196-198.
  15. Kumar SM: Photoselective vaporization of the prostate: a volume reduction analysis in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia and carcinoma of the prostate. J Urol 2005, 173, 511-513.
  16. Malek RS, Nahen K: Photoselective vaporization of the prostate: KTP laser therapy of obstructive Benign Prostatic Hyperplasia. AUA Update Series 2004, 23,153-159.
  17. Kuntzmann RS, Malek RS, Barrett DM, Bostwick DG: Potassium-Titanyl-Phosphate laser vaporization of the prostate: a comparative functional and pathologic study in canines. Urology 1996, 48, 575-583.
  18. Kuntzmann RS, Malek RS, Barrett DM, Bostwick DG: High power (60-Watt) Potassium-Titanyl-Phosphate laser vaporization prostatectomy in living canines and in human and canine cadavers. Urology 1997, 49, 703-708.
  19. Malek RS, Barrett DM, Kuntzmann RS: High-power Potassium-Titanyl-
  20. -Phosphate (KTP/532) laser vaporization prostatectomy: 24 hours later. Urology 1998, 51, 254-256.
  21. Malek RS, Kuntzmann RS, Barrett DM: High-power Potassium-Titanyl-Phosphate laser vaporization prostatectomy. J Urol 2000, 163, 1730-1733.
  22. Hai MA, Malek RS: Photoselective vaporization of the prostate: initial experience with a new 80 W KTP laser for the treatment of benign prostatic hyperplasia. J Endourol 2003, 17, 93-96.
  23. Te AE, Malloy TR, Stein BS et al: Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first united states multicenter prospective trial. J Urol 2004, 172, 1404-1408.
  24. Barber NJ, Zhu G, Donohue JF et al: Use of expired breath ethanol measurements in evaluation of irrigant absorption during high-power potassium titanyl phosphate laser vaporization of prostate. Urology 2006, 67, 80-83.
  25. Malek RS, Kuntzmann RS, Barrett DM: Photoselective Potassium-Titanyl-Phosphate laser vaporization of the benign obstructive prostate: observations on long-term outcomes. J Urol 2005, 174, 1344-1348.
  26. Reich O, Bachmann A, Siebels M et al: High power (80 W) Potassium-Titanyl-Phosphate laser vaporization of the prostate in 66 high risk patients. J Urol 2005, 173, 158-160.
  27. Sandhu JS, Ng C, Gonzalez RR, Kaplan SA, Te AE: Photoselective laser vaporization prostatectomy in men receiving anticoagulants. J Endourol 2005, 19, 1196-1198.
  28. Sandhu JS, Ng C, Vanderbrink BA, Egan C et al: High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates. Urology 2004, 64, 1155-1159.
  29. Yakupoglu YK: Successful treatment of benign prostatic hyperplasia over 100 ml with KTP laser. Praca prezentowana na AUA Meeting 2006.
  30. Bachmann A, Schurch L, Ruszat R et al: Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): A prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol 2005, 48, 965-971.
  31. Bouchier Hayes DM, Andeerson P, Van Appledorn S et al: KTP Laser versus Transurethral resection: early results of a randomized trial. J Endourol 2006, 20, 580-585.
  32. Stovsky MD, Griffiths RI, Duff SB: A clinical outcomes and cost analysis comparing photoselective vaporization of the prostate to alternative minimally invasive therapies and transurethral prostate resection for the treatment of benign prostatic hyperplasia. J Urol 2006, 176, 1500-1506.

correspondence

Henryk Zieliński
Klinika Urologii CSK MON
ul. Szaserów 128
04-349 Warszawa
tel. (022) 681 63 19
urologia@wim.mil.pl